Trial Profile
A Phase I Combination Study of AZD2281 and Cisplatin Plus Gemcitabine in Adults With Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary) ; Olaparib (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacodynamics
- 18 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.